CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Top Cited Papers
- 8 March 2006
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 440 (7083), 540-544
- https://doi.org/10.1038/nature04606
Abstract
Naive lymphocytes continually enter and exit lymphoid organs in a recirculation process that is essential for immune surveillance. During immune responses, the egress process can be shut down transiently1. When this occurs locally it increases lymphocyte numbers in the responding lymphoid organ; when it occurs systemically it can lead to immunosuppression as a result of the depletion of recirculating lymphocytes. Several mediators of the innate immune system are known to cause shutdown, including interferon α/β (IFN-α/β) and tumour necrosis factor2,3,4,5, but the mechanism has been unclear. Here we show that treatment with the IFN-α/β inducer polyinosine polycytidylic acid (hereafter ‘poly(I:C)’) inhibited egress by a mechanism that was partly lymphocyte-intrinsic. The transmembrane C-type lectin CD69 was rapidly induced and CD69-/- cells were poorly retained in lymphoid tissues after treatment with poly(I:C) or infection with lymphocytic choriomeningitis virus. Lymphocyte egress requires sphingosine 1-phosphate receptor-1 (S1P1), and IFN-α/β was found to inhibit lymphocyte responsiveness to S1P. By contrast, CD69-/- cells retained S1P1 function after exposure to IFN-α/β. In coexpression experiments, CD69 inhibited S1P1 chemotactic function and led to downmodulation of S1P1. In a reporter assay, S1P1 crosslinking led to co-crosslinking and activation of a CD69–CD3ζ chimaera. CD69 co-immunoprecipitated with S1P1 but not the related receptor, S1P3. These observations indicate that CD69 forms a complex with and negatively regulates S1P1 and that it functions downstream of IFN-α/β, and possibly other activating stimuli, to promote lymphocyte retention in lymphoid organs.Keywords
This publication has 28 references indexed in Scilit:
- Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zoneNature Immunology, 2004
- Sphingosine 1-phosphate pathway therapeutics: a lipid ligand–receptor paradigmCurrent Opinion in Chemical Biology, 2003
- CD69‐null mice protected from arthritis induced with anti‐type II collagen antibodiesInternational Immunology, 2003
- Enhanced Antitumor Immunity in Mice Deficient in CD69The Journal of Experimental Medicine, 2003
- Activation‐regulated expression and chemotactic function of sphingosine 1‐phosphate receptors in mouse splenic T cellsThe FASEB Journal, 2002
- Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell ReceptorsScience, 2002
- Transcriptional Regulation of the Gene Encoding the Human C-type Lectin Leukocyte Receptor AIM/CD69 and Functional Characterization of Its Tumor Necrosis Factor-α-responsive ElementsPublished by Elsevier ,1995
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994
- Pertussis toxin inhibits activation-induced cell death of human thymocytes, pre-B leukemia cells and monocytes.The Journal of Experimental Medicine, 1994
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994